HAE
Haemonetics Corporation
106.00$
-0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.5% | – | -142.8% | – | -10.4% | +166.3% | -85.1% | +540.0% | -16.0% | -24.2% | -26.2% | – | |
| – | +2.3% | +17.5% | +5.4% | +0.3% | -0.7% | -2.8% | +1.9% | -1.7% | -3.1% | -0.2% | -0.8% | – | |
| – | +7.6% | +2.8% | +2.8% | -10.1% | +19.8% | -15.5% | +34.2% | -18.5% | +2.8% | +17.0% | +2.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -313.1% | – | -755.7% | – | – | – | -235.3% | – | -54.7% | -151.4% | – | – | |
| – | -9.6% | -56.6% | -41.6% | +66.8% | -9.4% | +83.0% | -76.0% | +33.6% | +26.6% | +178.2% | -55.2% | – | |
| – | +970.0% | -95.1% | +966.2% | -83.2% | -25.7% | – | -282.9% | -7.7% | -3.3% | +193.9% | -74.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +35.0% | -1.8% | +68.7% | +669.2% | -87.0% | +1,438.5% | -96.8% | +1,468.7% | – | -233.3% | -96.5% | – | |
| – | – | – | – | – | – | +0.1% | +0.0% | -0.1% | +0.1% | -0.1% | +3,201.1% | – | |
| – | – | -158.0% | – | -122.4% | – | -11,074.6% | -98.4% | +3,034.8% | – | -5,092.6% | -49.2% | – | |
| – | -340.5% | – | – | -127.3% | – | -165.3% | – | – | +1,797.4% | -276.2% | – | – | |
| – | -130.7% | – | -160.8% | – | -10.6% | +186.5% | -86.5% | +679.3% | -18.0% | -38.9% | -16.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.